National Health Investors (National Health Investors) Days Sales Outstanding

: 102.40 (As of Dec. 2023)

View and export this data going back to 1991. Start your Free Trial

National Health Investors's average Accounts Receivable for the three months ended in Dec. 2023 was $89.2 Mil. National Health Investors's Revenue for the three months ended in Dec. 2023 was $79.5 Mil. Hence, National Health Investors's Days Sales Outstanding for the three months ended in Dec. 2023 was 102.40.

The historical rank and industry rank for National Health Investors's Days Sales Outstanding or its related term are showing as below:

NHI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 61.86 Med: 110.9 Max: 131.19
Current: 99.52

During the past 13 years, National Health Investors's highest Days Sales Outstanding was 131.19. The lowest was 61.86. And the median was 110.90.

NHI's Days Sales Outstanding is ranked worse than
87.3% of 622 companies
in the REITs industry
Industry Median: 22.275 vs NHI: 99.52

National Health Investors's Days Sales Outstanding declined from Dec. 2022 (105.76) to Dec. 2023 (102.40).

National Health Investors Days Sales Outstanding Historical Data

The historical data trend for National Health Investors's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Health Investors Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

115.47

102.85

120.79

118.91

97.85

National Health Investors Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding																105.76	93.58	103.01	101.06	102.40

Competitive Comparison

For the REIT - Healthcare Facilities subindustry, National Health Investors's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

National Health Investors Days Sales Outstanding Distribution

For the REITs industry and Real Estate sector, National Health Investors's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where National Health Investors's Days Sales Outstanding falls into.

National Health Investors Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

National Health Investors's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (81.857	+	89.629)	/	2 )	/	319.835	*	365
=	85.743					/	319.835	*	365
=	97.85

National Health Investors's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (88.724	+	89.629)	/	2 )	/	79.465	*	365 / 4
=	89.1765					/	79.465	*	365 / 4
=	102.40

National Health Investors (NYSE:NHI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

National Health Investors Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of National Health Investors's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

National Health Investors (National Health Investors) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » National Health Investors Inc (NYSE:NHI) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

WX6:Germany

Address

222 Robert Rose Drive, Murfreesboro, TN, USA, 37129

Website

https://www.nhireit.com

National Health Investors Inc is a housing and medical facility REIT. The company operate through two reportable segments i.e. Real Estate Investments and Senior Housing Operating Portfolio. Real Estate Investments segment consists of real estate investments and lease, mortgage and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. SHOP segment is comprised of two ventures that own the operations of independent living facilities. Company's revenues are derived from rental income, mortgage and other notes receivable interest income and resident fees and services.

Executives

James R Jobe	director	707 REGAL DRIVE, MURFREESBORO TN 37129
Robert G Adams	director, officer: President	P.O. BOX 1398, MURFREESBORO TN 37133-1398
Colden Tracy M J	director	C/O PLAYA HOTELS & RESORTS N.V.,, 3950 UNIVERSITY DRIVE, SUITE 301, FAIRFAX VA 22030
Robert T Webb	director	PO BOX 1102, MURFREESBORO TN 37133-1102
D. Eric Mendelsohn	officer: EVP - Corporate Finance	C/O EMERITUS CORPORATION, 3131 ELLIOTT AVENUE, SUITE 500, SEATTLE WA 98121
Mccabe Robert A Jr	director	500 CHURCH ST, STE 200, NASHVILLE TN 37219
David L Travis	officer: SVP/Chief Accounting Officer	C/O MEDEQUITIES REALTY TRUST, 3100 WEST END AVENUE, SUITE 1000, NASHVILLE TN 37203
W Andrew Adams	director, officer: President	P.O. BOX 1398, MURFREESBORO TN 37133-1398
Kevin Carlton Pascoe	officer: EVP - Investments	222 ROBERT ROSE DRIVE, MURFREESBORO TN 37129
Ronald V Reel	officer: Chief Accounting Officer	222 ROBERT ROSE DRIVE, MURFREESBORO TN 37129
Kristin Sallee Gaines	officer: Chief Credit Officer	2320 LONDONDERRY DRIVE, MURFREESBORO TN 37129
John L Spaid	officer: Exec. VP of Finance	222 ROBERT ROSE DRIVE, MURFREESBORO TN 37129
Roger R Hopkins	officer: Chief Accounting Officer	2930 PRINCETON LANE, MURFREESBORO TN 37129
James Justin Hutchens	officer: President and COO	C/O VENTAS, INC., 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Ted H Welch	director	PO BOX 1102, MURFREESBORO TN 37133-1102